Acknowledgements


The ESP and BDIAP gratefully acknowledge the support of the following companies for the 32nd Congress of the ESP and the XXXIII International Congress of the IAP:

Premium Sponsor

AstraZeneca


Major Sponsors

Amgen (Europe) GmbH

Bristol Myers Squibb


Bristol Myers Squibb

Main Sponsor


Thermo Fisher Scientific

Further Sponsors and Exhibitors

A. MENARINI DIAGNOSTICS
Agilent Technologies
ArcherDX

Bayer

Biocartis
Cirdan
ContextVision

Daiichi Sankyo Europe GmbH

Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address unmet medical needs. With more than 100 years of scientific expertise and a presence 
in more than 20 countries, Daiichi Sankyo and its 15,000 employees draw upon 
a rich legacy of innovation and a robust pipeline of promising new medicines.

Our 2025 Vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories. More information: www.daiichi-sankyo.eu.

DeePathology.ai
ENEA BRIVIO
EXACT SCIENCES
Frontiers
Ibex Medical Analytics
Innovation Science Press
Lunaphore
Merck KGaA
MILSTONE S.r.l.
Myriad Genetics
Nanostring Technologies
Novartis
Olympus
Paige
Philips
Primera Technology, Inc.
Roche
Visiopharm A/S
WILEY
 

 

 

 

The ESP and BDIAP gratefully acknowledge the support of: